156 related articles for article (PubMed ID: 38125796)
21. [Pro and contra lymphadenectomy in papillary and follicular thyroid gland carcinoma].
Seiler CA; Schäfer M; Büchler MW
Zentralbl Chir; 2000; 125(10):835-40; discussion 840-1. PubMed ID: 11098579
[TBL] [Abstract][Full Text] [Related]
22. Differentiated thyroid cancer: role of the lymph node dissection.
Caglià P; Zappulla E; Costa S; Tracia M; Veroux M; Russo V; Borzì L; Lucifora B; Patanè G; Tracia L; Amodeo C
G Chir; 2010; 31(6-7):293-5. PubMed ID: 20646374
[TBL] [Abstract][Full Text] [Related]
23. Lymph nodes metastases in differentiated thyroid cancer--prognostic value and surgical results with 430 patients for 30 years period (1980-2010).
Petkov R; Katev N; Todorov G; Mladenovski V; Yaramov N; Sokolov M
Khirurgiia (Sofiia); 2011; (1):5-11. PubMed ID: 23847796
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients.
Gambardella C; Tartaglia E; Nunziata A; Izzo G; Siciliano G; Cavallo F; Mauriello C; Napolitano S; Thomas G; Testa D; Rossetti G; Sanguinetti A; Avenia N; Conzo G
World J Surg Oncol; 2016 Sep; 14(1):247. PubMed ID: 27644091
[TBL] [Abstract][Full Text] [Related]
25. Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks.
Ito Y; Miyauchi A
World J Surg; 2007 May; 31(5):905-15. PubMed ID: 17219265
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcomes of central neck dissection for cN0 papillary thyroid carcinoma.
Giordano D; Frasoldati A; Gabrielli E; Pernice C; Zini M; Castellucci A; Piana S; Ciarrocchi A; Cavuto S; Barbieri V
Am J Otolaryngol; 2017; 38(5):576-581. PubMed ID: 28599790
[TBL] [Abstract][Full Text] [Related]
27. Total thyroidectomy for differentiated thyroid carcinoma: primary and secondary operations.
Eroğlu A; Unal M; Kocaoğlu H
Eur J Surg Oncol; 1998 Aug; 24(4):283-7. PubMed ID: 9724994
[TBL] [Abstract][Full Text] [Related]
28. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons.
Takami H; Ito Y; Okamoto T; Yoshida A
World J Surg; 2011 Jan; 35(1):111-21. PubMed ID: 21042913
[TBL] [Abstract][Full Text] [Related]
30. Non-suppressed thyrotropin and elevated thyroglobulin are independent predictors of recurrence in differentiated thyroid carcinoma.
Böhm J; Kosma VM; Eskelinen M; Hollmen S; Niskanen M; Tulla H; Alhava E; Niskanen L
Eur J Endocrinol; 1999 Nov; 141(5):460-7. PubMed ID: 10576761
[TBL] [Abstract][Full Text] [Related]
31. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
32. Papillary thyroid cancer: controversies in the management of neck metastasis.
Davidson HC; Park BJ; Johnson JT
Laryngoscope; 2008 Dec; 118(12):2161-5. PubMed ID: 19029855
[TBL] [Abstract][Full Text] [Related]
33. [Completion total thyroidectomy in children with differentiated thyroid cancer].
Handkiewicz-Junak D; Włoch J; Czarniecka A; Roskosz J; Prokurat A; Pomorski L; Krajewska J; Kropińska A; Kukulska A; Jarzab B
Endokrynol Pol; 2006; 57(4):356-61. PubMed ID: 17006836
[TBL] [Abstract][Full Text] [Related]
34. [Surgical treatment of recurrent thyroid carcinoma after primary resection].
Kohara N; Furui J; Tomioka T; Motojima K; Tsunoda T; Kanematsu T
Nihon Geka Gakkai Zasshi; 1993 Aug; 94(8):847-52. PubMed ID: 8377761
[TBL] [Abstract][Full Text] [Related]
35. Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.
Lin X; Chen X; Jiru Y; Du J; Zhao G; Wu Z
Bull Cancer; 2016 Jun; 103(6):535-40. PubMed ID: 27236850
[TBL] [Abstract][Full Text] [Related]
36. Total thyroidectomy with therapeutic level II-IV neck dissection for papillary thyroid carcinoma: level VI recurrence patterns.
Carmel-Neiderman NN; Duek I; Amsterdam D; Wengier A; Kuzmenko B; Ringel B; Warshavsky A; Shapira U; Horowitz G; Izkhakov E; Fliss DM
Eur Arch Otorhinolaryngol; 2020 Dec; 277(12):3449-3455. PubMed ID: 32488373
[TBL] [Abstract][Full Text] [Related]
37. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
[TBL] [Abstract][Full Text] [Related]
38. Long-Term Outcomes of Lateral Neck Dissection in Patients with Recurrent or Persistent Well-Differentiated Thyroid Cancer.
Chinn SB; Zafereo ME; Waguespack SG; Edeiken BS; Roberts DB; Clayman GL
Thyroid; 2017 Oct; 27(10):1291-1299. PubMed ID: 28806882
[TBL] [Abstract][Full Text] [Related]
39. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
[TBL] [Abstract][Full Text] [Related]
40. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
